Sugi Predict

Sugi Predict / Compounds / SCHEMBL7186691

SCHEMBL7186691

SCHEMBL7186691

O=C(c1c(Cl)cccc1Cl)[P](=O)C(=O)c1c(Br)cccc1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ F2R P25116 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ FEN1 P39748 1/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ NOTUM Q6P988 1/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ JAK1 P23458 1/20 0.34
▸ TYK2 P29597 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ ITGB1 P05556 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29282733 0.76 ALDH1A1 (0.44) ALDH1A1HPGDNPC1GLAFEN1
SCHEMBL2844436 0.76 ALDH1A1 (0.71) ALDH1A1HPGDNPC1GLAF2R
SCHEMBL696250 0.76 ALDH1A1 (0.52) ALDH1A1HPGDNPC1GLAF2R
Decane SCHEMBL8529247 0.75 PLK1 (0.44) ALDH1A1HPGDKMT2AMEN1
SCHEMBL8262560 0.75 ALDH1A1 (0.50) ALDH1A1HPGDNPC1GLAF2R
SCHEMBL793494 0.75 ALDH1A1 (0.50) ALDH1A1HPGDNPC1GLAF2R
Hydrochloric Acid SCHEMBL7952153 0.75 ALDH1A1 (0.50) ALDH1A1HPGDNPC1GLAF2R
SCHEMBL7186686 0.70 ALDH1A1 (0.45) ALDH1A1HPGDNPC1GLAF2R
SCHEMBL852447 0.70 CA12 (0.52) ALDH1A1HPGDF2RTDP1L3MBTL1
SCHEMBL80182 0.68 ALDH1A1 (0.64) ALDH1A1HPGDNPC1GLAFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ALDH1A1 3416/4885HPGD 3983/4885NPC1 772/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885HPGD 4041/4885NPC1 872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.